Manganese levels in newborns' hair by maternal sociodemographic, dietary and environmental factors.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
03 2019
Historique:
received: 17 07 2018
revised: 21 11 2018
accepted: 22 11 2018
pubmed: 24 12 2018
medline: 18 12 2019
entrez: 22 12 2018
Statut: ppublish

Résumé

Exposure to manganese (Mn) has been associated with neurodevelopmental problems in children. Mn exposure begins in utero, and maternal sociodemographic, dietary and environmental factors may affect Mn levels in newborns' hair. This study aimed to characterize in utero Mn exposure using Mn levels in newborns' hair as a biomarker of prenatal exposure, and to analyze its relationship with sociodemographic, dietary and environmental factors in the Spanish INMA-Gipuzkoa cohort. Overall, 638 pregnant women were recruited in the first trimester of pregnancy and a hair sample was obtained from 473 newborns. Sociodemographic, dietary and environmental data were recorded through two questionnaires administered in the first and third trimesters of pregnancy. The median Mn concentration in newborns´ hair was 0.31 µg/g (P5 = 0.02; P95 = 1.23). Mn levels in newborns´ hair were associated with smoking during pregnancy (β = 0.222; 95% CI = 0.065-0.379) and with maternal PM

Identifiants

pubmed: 30576994
pii: S0013-9351(18)30621-2
doi: 10.1016/j.envres.2018.11.038
pii:
doi:

Substances chimiques

Manganese 42Z2K6ZL8P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-100

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

A Irizar (A)

BIODONOSTIA Health Research Institute, Paseo Dr. Beguiristain, San Sebastian 20014, Spain. Electronic address: a-irizarloibide@euskadi.eus.

F Gil (F)

Department of Legal Medicine and Toxicology, School of Medicine, University of Granada, Spain.

A Lertxundi (A)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Department of Preventive Medicine and Public Health of the University of the Basque Country (UPV-EHU), Spain.

M C Martín-Domingo (MC)

Department of Legal Medicine and Toxicology, School of Medicine, University of Granada, Spain.

N Urbieta (N)

BIODONOSTIA Health Research Institute, Paseo Dr. Beguiristain, San Sebastian 20014, Spain.

A Molinuevo (A)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain.

J Ibarluzea (J)

BIODONOSTIA Health Research Institute, Paseo Dr. Beguiristain, San Sebastian 20014, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Public Health Division of Gipuzkoa, Basque Government, 4 Av. de Navarra, San Sebastian 20013, Spain.

M Basterrechea (M)

BIODONOSTIA Health Research Institute, Paseo Dr. Beguiristain, San Sebastian 20014, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Public Health Division of Gipuzkoa, Basque Government, 4 Av. de Navarra, San Sebastian 20013, Spain.

J J Aurrekoetxea (JJ)

BIODONOSTIA Health Research Institute, Paseo Dr. Beguiristain, San Sebastian 20014, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Public Health Division of Gipuzkoa, Basque Government, 4 Av. de Navarra, San Sebastian 20013, Spain; Department of Preventive Medicine and Public Health of the University of the Basque Country (UPV-EHU), Spain.

A Jiménez-Zabala (A)

Public Health Division of Gipuzkoa, Basque Government, 4 Av. de Navarra, San Sebastian 20013, Spain.

L Santa-Marina (L)

BIODONOSTIA Health Research Institute, Paseo Dr. Beguiristain, San Sebastian 20014, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Public Health Division of Gipuzkoa, Basque Government, 4 Av. de Navarra, San Sebastian 20013, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH